Search results
Moderna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year
Fortune· 5 days agoIn the first quarter of the year, Moderna reported $167 million in sales of its only product on the market, its COVID-19 vaccine called Spikevax. The company’s first quarter revenue is down ...
Biotech’s bind over China bill
Politico· 4 days agoBancel suggested the shot’s presentation — a pre-filled syringe — could be a game-changing differentiator for busy health care providers. GSK and Pfizer make RSV vaccines ...
Moderna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year
AOL· 5 days agoThe dark days of the pandemic are finally in the past for most of us—and that seems to be reflected in the earnings for Moderna, whose revenue is dependent on sales of its COVID-19 vaccine.